Cellectis S.A.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
other
SEC Category
Accelerated filer
State of Incorporation
France
Country
France
Business Address
8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE, ,
Mailing Address
8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE, ,
Phone
33181691600
Fiscal Year End
1231
EIN
000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 20, 2026 | View on SEC |
| 20-F Foreign company annual report | March 20, 2026 | View on SEC |
| 6-K Foreign company current report | March 12, 2026 | View on SEC |
| 6-K Foreign company current report | January 8, 2026 | View on SEC |
| 6-K Foreign company current report | December 15, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | December 12, 2025 | View on SEC |
| 6-K Foreign company current report | December 8, 2025 | View on SEC |
| 6-K Foreign company current report | December 5, 2025 | View on SEC |
| 6-K Foreign company current report | November 19, 2025 | View on SEC |
| 6-K Foreign company current report | November 7, 2025 | View on SEC |
Annual Reports
20-F
March 20, 2026
- Formed a significant partnership with AstraZeneca in November 2023, validating its gene-editing technology and securing funding.
- Strategically refocused on its core 'off-the-shelf' CAR T-cell programs for cancer by selling Calyxt Inc. in May 2023.
Related Companies
Companies in the same industry (SIC: 2836)
NEUROCRINE BIOSCIENCES INC
NBIX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Replimune Group, Inc.
REPL
Biological Products, (No Diagnostic Substances)
BioAtla, Inc.
BCAB
Biological Products, (No Diagnostic Substances)
Vericel Corp
VCEL
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.